The first such medication-- a model of GLP-1 originated from a Gila monster-- was approved for individuals with type 2 diabetic issues in 2005, and the very first version based on human GLP-1 was accepted for type 2 diabetic issues therapy in 2010. " That's the beauty of GLP-1," stated Bjerre Knudsen, referring to collaborative job across many sectors. Aronne's initiatives reflect the importance of clinicians in GLP-1 drugs' success, laying the groundwork for obesity medication as an area, an...